IL4I1⁺ Macrophages and TDO2⁺ Myofibroblasts Drive AhR‐Mediated Immunosuppression and Ferroptosis Resistance in Solid Predominant Lung Adenocarcinoma
Advanced Science · 2026-03 · 13 (13)
DOI: 10.1002/advs.202513606 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 22.12.2025. Verfasst von Zhaoxuan Wang und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian, China. Hauptthemen laut MEDLINE: Ferroptosis, Receptors, Aryl Hydrocarbon, Adenocarcinoma of Lung, Lung Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Dalian Science and Technology Innovation Fund, Dalian Key Medical Specialty Dengfeng Project.
Abstract (Originalsprache)
Lung adenocarcinoma (LUAD) displays marked intratumoral heterogeneity with distinct histological patterns. The solid pattern representing poorly differentiated LUAD is linked to poor prognosis and therapeutic resistance. To uncover underlying mechanisms, we integrate bulk and single‐cell RNA sequencing and identify a preferential enrichment of interleukin 4 induced 1 (IL4I1)‐expressing tumor‐associated macrophages (TAMs) and tryptophan 2,3‐dioxygenase (TDO2)‐expressing myofibroblastic cancer‐associated fibroblasts (myCAFs) in a solid pattern of LUAD. Spatial transcriptomics reveals their co‐localization in peritumoral stroma, forming an immune‐excluded niche. Mechanistically, TDO2⁺ myCAFs promoted monocyte‐to‐IL4I1⁺ TAM differentiation via the kynurenine‐aryl hydrocarbon receptor (AhR) axis. Tryptophan metabolomic landscapes confirm that IL4I1⁺ TAMs and TDO2⁺ myCAFs enhance tryptophan degradation and accumulation of AhR ligands (e.g., kynurenine, indole‐3‐carboxaldehyde), contributing to CD8⁺ T cell exhaustion and anti‐PD‐1 therapeutic resistance. IL4I1⁺ TAMs and TDO2⁺ myCAFs conformably mediate ferroptosis resistance through the AhR‐NRF2‐GPX4‐SLC7A11 pathway. Notably, AhR antagonist CH‐223191 restores ferroptosis sensitivity of tumor cells. A triple therapy combining CH‐223191, ferroptosis inducer (Imidazole ketone erastin or RSL3), and anti‐PD‐1 agent demonstrates superior efficacy and safety in vivo. Together, our findings demonstrate that IL4I1⁺ TAMs and TDO2⁺ myCAFs synergistically establish an immunosuppressive, ferroptosis‐resistant niche via AhR signaling in solid predominant LUAD and offer promising therapeutic strategies to reprogram the tumor microenvironment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thoracic Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian, China.
- Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Key Laboratory of Thoracic Tumor Biotherapy, Shanghai, China.
- Department of Pathology, The First Affiliated Hospital of Dalian Medical University, Dalian, China.
- Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
- Department of Oncology, The Second Hospital of Dalian Medical University, Dalian, China.
ORCID-Profile: Zhaoxuan Wang
Förderung
- National Natural Science Foundation of China
- Dalian Science and Technology Innovation Fund
- Dalian Key Medical Specialty Dengfeng Project
Zitieren
APA
Wang, Z., Xu, W., Zhao, L., Zhong, L., Yu, W., Wang, S., Sun, L., Guo, T., Li, F., Li, Z., Fang, L., Wang, S., Zhang, G., Xue, G., Guo, W., Zhao, S., & Gu, C. (2026). IL4I1⁺ Macrophages and TDO2⁺ Myofibroblasts Drive AhR‐Mediated Immunosuppression and Ferroptosis Resistance in Solid Predominant Lung Adenocarcinoma. Advanced Science, 13(13). https://doi.org/10.1002/advs.202513606
Vancouver
Wang Z, Xu W, Zhao L, Zhong L, Yu W, Wang S, et al. IL4I1⁺ Macrophages and TDO2⁺ Myofibroblasts Drive AhR‐Mediated Immunosuppression and Ferroptosis Resistance in Solid Predominant Lung Adenocarcinoma. Advanced Science. 2026;13(13). doi:10.1002/advs.202513606
BibTeX
@article{Wang2026,
author = {Wang, Zhaoxuan and Xu, Weijiao and Zhao, Lei and Zhong, Lin and Yu, Wendan and Wang, Shengmin and Sun, Lu and Guo, Tao and Li, Fengzhou and Li, Zhuoshi and Fang, Lei and Wang, Shiqing and Zhang, Guohui and Xue, Guoqing and Guo, Wei and Zhao, Shilei and Gu, Chundong},
title = {IL4I1⁺ Macrophages and TDO2⁺ Myofibroblasts Drive AhR‐Mediated Immunosuppression and Ferroptosis Resistance in Solid Predominant Lung Adenocarcinoma},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {13},
doi = {10.1002/advs.202513606}
}
EUVIMED